Gastroesophageal Reflux
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
EGD - If You Have Symptoms That Do Not Go Away, Like Heartburn, Vomiting Or Belly Pain, You May Need an Upper Endoscopy
EGD - if you have symptoms that do not go away, like heartburn, vomiting or belly pain, you may need an upper endoscopy. An upper endoscopy is also known as an esophagogastroduodenoscopy (EGD). It is a test that enables doctors to examine the upper digestive tract, which includes the: • Esophagus (“food tube” that connects the mouth to the stomach) • Stomach • Duodenum (upper part of the small intestine) An EGD uses an endoscope, which is a long, flexible tube with a camera and light at its tip. The doctor carefully guides the endoscope through the mouth and down the throat to view the upper digestive tract to view images of the digestive tract and can take color photos of specific areas. They may take a biopsy (tissue sample) of abnormal tissue, such as growths, irritations or ulcers, which are sores in the intestine’s lining. Esophageal dilation - Esophageal dilation is a procedure that allows your doctor to dilate, or stretch, a narrowed area of your esophagus [swallowing tube]. Doctors can use various techniques for this procedure while your are sedated during your EGD. Flexible Sigmoidoscopy - A sigmoidoscope is a slender, flexible tube with a light and a very small video camera at the end of it. It is shorter than a colonoscope and is only able to evaluate the lower third of the colon. This allows a look at the inside of the rectum and lower part of the colon for cancer or polyps. Before the test, you will need to take an enema or other prep to clean out the lower colon, but a full cleansing solution is not needed as in colonoscopy. -
“A Dissertation on Endoscopic Biopsy Yield in Upper Gastrointestinal Malignancies” Dissertation Submitted To
“A DISSERTATION ON ENDOSCOPIC BIOPSY YIELD IN UPPER GASTROINTESTINAL MALIGNANCIES” DISSERTATION SUBMITTED TO THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY In partial fulfillment of the regulations for the award of the M.S.DEGREE EXAMINATION BRANCH I GENERAL SURGERY DEPARTMENT OF GENERAL SURGERY STANLEY MEDICAL COLLEGE AND HOSPITAL THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY CHENNAI APRIL 2015 CERTIFICATE This is to certify that the dissertation titled “A DISSERTATION ON ENDOSCOPIC BIOPSY YIELD IN UPPER GASTROINTESTINAL MALIGNANCIES” is the bonafide work done by Dr. P.ARAVIND, Post Graduate student (2012 – 2015) in the Department of General Surgery, Government Stanley Medical College and Hospital, Chennai under my direct guidance and supervision, in partial fulfillment of the regulations of The Tamil Nadu Dr. M.G.R Medical University, Chennai for the award of M.S., Degree (General Surgery) Branch - I, Examination to be held in April 2015. Prof.DR.C.BALAMURUGAN M.S Prof.DR.S.VISWANATHAN M.S Professor of Surgery Professor and Dept. of General Surgery, Head of the Department, Stanley Medical College, Dept. of General Surgery, Chennai-600001. Stanley Medical College, Chennai-600001. PROF. DR.AL.MEENAKSHISUNDARAM, M.D., D.A., The Dean, Stanley Medical College, Chennai - 600001. DECLARATION I, DR.P.ARAVIND solemnly declare that this dissertation titled “A DISSERTATION ON ENDOSCOPIC BIOPSY YIELD IN UPPER GASTROINTESTINAL MALIGNANCIES” is a bonafide work done by me in the Department of General Surgery, Government Stanley Medical College and Hospital, Chennai under the guidance and supervision of my unit chief. Prof. DR.C.BALAMURUGAN, Professor of Surgery. This dissertation is submitted to The Tamilnadu Dr.M.G.R. -
Abdominal Pain - Gastroesophageal Reflux Disease
ACS/ASE Medical Student Core Curriculum Abdominal Pain - Gastroesophageal Reflux Disease ABDOMINAL PAIN - GASTROESOPHAGEAL REFLUX DISEASE Epidemiology and Pathophysiology Gastroesophageal reflux disease (GERD) is one of the most commonly encountered benign foregut disorders. Approximately 20-40% of adults in the United States experience chronic GERD symptoms, and these rates are rising rapidly. GERD is the most common gastrointestinal-related disorder that is managed in outpatient primary care clinics. GERD is defined as a condition which develops when stomach contents reflux into the esophagus causing bothersome symptoms and/or complications. Mechanical failure of the antireflux mechanism is considered the cause of GERD. Mechanical failure can be secondary to functional defects of the lower esophageal sphincter or anatomic defects that result from a hiatal or paraesophageal hernia. These defects can include widening of the diaphragmatic hiatus, disturbance of the angle of His, loss of the gastroesophageal flap valve, displacement of lower esophageal sphincter into the chest, and/or failure of the phrenoesophageal membrane. Symptoms, however, can be accentuated by a variety of factors including dietary habits, eating behaviors, obesity, pregnancy, medications, delayed gastric emptying, altered esophageal mucosal resistance, and/or impaired esophageal clearance. Signs and Symptoms Typical GERD symptoms include heartburn, regurgitation, dysphagia, excessive eructation, and epigastric pain. Patients can also present with extra-esophageal symptoms including cough, hoarse voice, sore throat, and/or globus. GERD can present with a wide spectrum of disease severity ranging from mild, intermittent symptoms to severe, daily symptoms with associated esophageal and/or airway damage. For example, severe GERD can contribute to shortness of breath, worsening asthma, and/or recurrent aspiration pneumonia. -
Recent Insights Into the Biology of Barrett's Esophagus
Recent insights into the biology of Barrett’s esophagus Henry Badgery,1 Lynn Chong,1 Elhadi Iich,2 Qin Huang,3 Smitha Rose Georgy,4 David H. Wang,5 and Matthew Read1,6 1Department of Upper Gastrointestinal Surgery, St Vincent’s Hospital, Melbourne, Australia 2Cancer Biology and Surgical Oncology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia 3Department of Pathology and Laboratory Medicine, Veterans Affairs Boston Healthcare System and Harvard Medical School, West Roxbury, Massachusetts 4Department of Anatomic Pathology, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Melbourne, Australia 5Department of Hematology and Oncology, UT Southwestern Medical Centre and VA North Texas Health Care System, Dallas, Texas 6Department of Surgery, The University of Melbourne, St Vincent’s Hospital, Melbourne, Australia Address for correspondence: Dr Henry Badgery Department of Surgery St Vincent’s Hospital 41 Victoria Parade, Fitzroy, Vic, Australia, 3065 [email protected] Short title: Barrett’s biology This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/nyas.14432. This article is protected by copyright. All rights reserved. Keywords: Barrett’s esophagus; signaling pathways; esophageal adenocarcinoma; epithelial barrier function; molecular reprogramming Abstract Barrett’s esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), an aggressive cancer with a poor prognosis. Our understanding of the pathogenesis and of Barrett’s metaplasia is incomplete, and this has limited the development of new therapeutic targets and agents, risk stratification ability, and management strategies. -
Mechanisms Protecting Against Gastro-Oesophageal Reflux: a Review
Gut: first published as 10.1136/gut.3.1.1 on 1 March 1962. Downloaded from Gut, 1962, 3, 1 Mechanisms protecting against gastro-oesophageal reflux: a review MICHAEL ATKINSON From the Department of Medicine, University ofLeeds, The General Infirmary at Leeds Thomas Willis in his Pharmaceutice Rationalis pub- tion which function to close this orifice. During the lished in 1674-5 clearly recognized that the oeso- 288 years which have elapsed since this description, phagus may be closed off from the stomach and it has become abundantly clear that a closing described 'a very rare case of a certain man of mechanism does indeed exist at the cardia but its Oxford [who did] show an almost perpetual vomit- nature remains the subject of dispute. ing to be stirred up by the shutting up of left orifice Willis was chiefly concerned with the failure of this [of the stomach]'. His diagrams (Fig. 1) of the mechanism to open and does not appear to have anatomy of the normal stomach show a band of appreciated its true physiological importance. Al- muscle fibres encircling the oesophagogastric junc- though descriptions of oesophageal ulcer are to be found in the writings ofJohn Hunter and of Carswell (1838), the pathogenesis of these lesions remained uncertain until 1879, when Quincke described three cases with ulcers of the oesophagus resulting from digestion by gastric juice. Thereafter peptic ulcer of the oesophagus became accepted as a pathological entity closely resembling peptic ulcer in the stomach http://gut.bmj.com/ in macroscopic and microscopic appearances. The clinical picture of peptic ulcer of the oesophagus was clearly described by Tileston in 1906 who noted substernal pain radiating to between the shoulders, dysphagia, vomiting, haematemesis, and melaena as the principal presenting features. -
The Short Esophagus—Lengthening Techniques
10 Review Article Page 1 of 10 The short esophagus—lengthening techniques Reginald C. W. Bell, Katherine Freeman Institute of Esophageal and Reflux Surgery, Englewood, CO, USA Contributions: (I) Conception and design: RCW Bell; (II) Administrative support: RCW Bell; (III) Provision of the article study materials or patients: RCW Bell; (IV) Collection and assembly of data: RCW Bell; (V) Data analysis and interpretation: RCW Bell; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Reginald C. W. Bell. Institute of Esophageal and Reflux Surgery, 499 E Hampden Ave., Suite 400, Englewood, CO 80113, USA. Email: [email protected]. Abstract: Conditions resulting in esophageal damage and hiatal hernia may pull the esophagogastric junction up into the mediastinum. During surgery to treat gastroesophageal reflux or hiatal hernia, routine mobilization of the esophagus may not bring the esophagogastric junction sufficiently below the diaphragm to provide adequate repair of the hernia or to enable adequate control of gastroesophageal reflux. This ‘short esophagus’ was first described in 1900, gained attention in the 1950 where various methods to treat it were developed, and remains a potential challenge for the contemporary foregut surgeon. Despite frequent discussion in current literature of the need to obtain ‘3 or more centimeters of intra-abdominal esophageal length’, the normal anatomy of the phrenoesophageal membrane, the manner in which length of the mobilized esophagus is measured, as well as the degree to which additional length is required by the bulk of an antireflux procedure are rarely discussed. Understanding of these issues as well as the extent to which esophageal shortening is due to factors such as congenital abnormality, transmural fibrosis, fibrosis limited to the esophageal adventitia, and mediastinal fixation are needed to apply precise surgical technique. -
Gastroenterology, Nutrition and Organ Transplantation
Gastroenterology, Nutrition and Organ Transplantation MEDICAL POLICY GROUP Co-chairs Katherine Dallow, MD, MPH • Vice President • Clinical Programs and Strategy Desiree Otenti, ANP, MPH, Senior Director • Medical Policy Administration October 27th 2020 12-2 pm Conference call only. Please email [email protected] for more information. Invited: Katherine Dallow, MD, MPH, co-chair (Medical Policy Administration), Desiree Otenti, ANP, co- chair, (Medical Policy Administration); Grace Baker, MSW, LCSW, (Medical Policy Administration); Laura Barry, RN, BSN, (Medical Policy Administration); Craig Haug, MD, (Surgery); Thomas Hawkins, MD, (Internal Medicine); Kenneth Duckworth, MD, (Psychiatry); Peter Lakin, R.Ph, (Pharmacy Operations); Thomas Kowalski, R.Ph, (Clinical Pharmacy) Invited Physician Guest(s): Representatives from the Massachusetts Society of Gastroenterology; Massachusetts Society of Organ Transplantation Policies with Upcoming Coverage Updates Transcatheter Arterial Effective 12/1/2020: Chemoembolization to Treat New investigational indications described for TACE as part of combination Primary or Metastatic Liver therapy (with radiofrequency ablation) for resectable or unresectable Malignancies (634) hepatocellular carcinoma. Policies with Coverage Updates in the Past 12 Months AIM guideline: Effective August 16, 2020: Advanced Vascular Imaging Aneurysm of the abdominal aorta or iliac arteries (930) • Added new indication for asymptomatic enlargement by imaging • Clarified surveillance intervals for stable aneurysms as follows: o Treated -
Esophageal Functional Disorders in the Pre-Operatory Evaluation of Bariatric Surgery
AG-2020-213 ORIGINAL ARTICLE doi.org/10.1590/S0004-2803.202100000-34 Esophageal functional disorders in the pre-operatory evaluation of bariatric surgery Eponina Maria de Oliveira LEMME1, Angela Cerqueira ALVARIZ2 and Guilherme Lemos Cotta PEREIRA3 Received: 28 September 2020 Accepted: 11 December 2020 ABSTRACT – Background – Obesity is an independent risk factor for esophageal symptoms, gastroesophageal reflux disease (GERD), and motor ab- normalities. When contemplating bariatric surgery, patients with obesity type III undergo esophagogastroduodenoscopy (EGD) and also esophageal manometry (EMN), and prolonged pHmetry (PHM) as part of their pre-operative evaluation. Objective – Description of endoscopy, manometry and pHmetry findings in patients with obesity type III preparing for bariatric surgery, and correlation of these findings with the presence of typical GERD symptoms. Methods – Retrospective study in which clinical symptoms of GERD were assessed, focusing on the presence of heartburn and regurgitation. All patients underwent EMN, PHM and most of them EGD. Results – 114 patients (93 females–81%), average age 36 years old, average BMI of 45.3, were studied. Typical GERD symptoms were referred by 43 (38%) patients while 71 (62%) were asymptomatic. Eighty two patients (72% of total) underwent EGD and 36 (42%) evidenced esophageal abnormalities. Among the abnormal findings, hiatal hernia was seen in 36%, erosive esophagitis (EE) in 36%, and HH+EE in 28%. An abnormal EMN was recorded in 51/114 patients (45%). The main abnormality was a hypotensive lower esophageal sphincter (LES) in 32%, followed by ineffective esophageal motility in 25%, nutcracker esophagus in 19%, IEM + hypotensive LES in 10%, intra-thoracic LES (6%), hypertensive LES (4%), aperistalsis (2%) and achalasia (2%). -
1 the Anatomy and Physiology of the Oesophagus
111 2 3 1 4 5 6 The Anatomy and Physiology of 7 8 the Oesophagus 9 1011 Peter J. Lamb and S. Michael Griffin 1 2 3 4 5 6 7 8 911 2011 location deep within the thorax and abdomen, 1 Aims a close anatomical relationship to major struc- 2 tures throughout its course and a marginal 3 ● To develop an understanding of the blood supply, the surgical exposure, resection 4 surgical anatomy of the oesophagus. and reconstruction of the oesophagus are 5 ● To establish the normal physiology and complex. Despite advances in perioperative 6 control of swallowing. care, oesophagectomy is still associated with the 7 highest mortality of any routinely performed ● To determine the structure and function 8 elective surgical procedure [1]. of the antireflux barrier. 9 In order to understand the pathophysiol- 3011 ● To evaluate the effect of surgery on the ogy of oesophageal disease and the rationale 1 function of the oesophagus. for its medical and surgical management a 2 basic knowledge of oesophageal anatomy and 3 physiology is essential. The embryological 4 Introduction development of the oesophagus, its anatomical 5 structure and relationships, the physiology of 6 The oesophagus is a muscular tube connecting its major functions and the effect that surgery 7 the pharynx to the stomach and measuring has on them will all be considered in this 8 25–30 cm in the adult. Its primary function is as chapter. 9 a conduit for the passage of swallowed food and 4011 fluid, which it propels by antegrade peristaltic 1 contraction. It also serves to prevent the reflux Embryology 2 of gastric contents whilst allowing regurgita- 3 tion, vomiting and belching to take place. -
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines 499
Journal of Pediatric Gastroenterology and Nutrition 49:498–547 # 2009 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Co-Chairs: ÃYvan Vandenplas and yColin D. Rudolph Committee Members: zCarlo Di Lorenzo, §Eric Hassall, jjGregory Liptak, ôLynnette Mazur, #Judith Sondheimer, ÃÃAnnamaria Staiano, yyMichael Thomson, zzGigi Veereman-Wauters, and §§Tobias G. Wenzl ÃUZ Brussel Kinderen, Brussels, Belgium, {Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, USA, {Division of Pediatric Gastroenterology, Nationwide Children’s Hospital, The Ohio State University, Columbus, OH, USA, §Division of Gastroenterology, Department of Pediatrics, British Columbia Children’s Hospital/University of British Columbia, Vancouver, BC, Canada, jjDepartment of Pediatrics, Upstate Medical University, Syracuse, NY, USA, ôDepartment of Pediatrics, University of Texas Health Sciences Center Houston and Shriners Hospital for Children, Houston, TX, USA, #Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA, ÃÃDepartment of Pediatrics, University of Naples -
Selecthealth Medical Policies Gastroenterology Policies
SelectHealth Medical Policies Gastroenterology Policies Table of Contents Policy Title Policy Last Number Revised Bravo PH Monitoring Probe 200 12/19/09 Colonic Manometry 619 10/02/17 Computed Tomography Colonography (CTC) Virtual Colonoscopy 399 04/22/10 DNA Analysis of Stool for Colon Cancer Screening (Cologuard) 260 09/16/21 Drug Monitoring in Inflammatory Bowel Disease 532 02/26/20 Endoscopic Ultrasonography (EUS) 118 05/31/16 Formulas And Other Enteral Nutrition 534 12/21/20 Gastric Pacing/Gastric Electrical Stimulation (GES) 585 05/27/20 Genetic Testing: CA 19-9 Testing 331 06/30/16 IB-Stim 637 10/14/19 Injectable Bulking Agents In The Treatment Of Fecal Incontinence 531 06/10/15 In-Vivo Detection of Mucosal Lesions with Endoscopy 574 10/15/15 LINX System For The Management of Gerd 520 01/28/13 Peroral Endoscopic Myotomy (POEM) for the Treatment of 588 06/06/16 Esophageal Achlasia Pillcam ESO (Esophagus) 278 08/18/08 Prognostic Serogenetic Testing for Crohn’s Disease (Prometheus® Monitr™) 484 04/06/21 Serologic Testing For Diagnosis of Inflammatory Bowel Disease 175 04/06/21 Serum Testing For Hepatic Fibrosis (Fibrospect II, The Fibrotest, and The 274 08/28/20 HCV-Fibrosure Test) Transcutaneous Electrical Stimulation Devices For Nausea and Vomiting 199 12/27/09 Transendoscopic Anti-Reflux Procedures 198 08/06/10 By accessing and/or downloading SelectHealth policies, you automatically agree to the Medical and Coding/ Reimbursement Policy Manual Terms and Conditions. Gastroenterology Policies, Continued MEDICAL POLICY BRAVO PH MONITORING PROBE Policy # 200 Implementation Date: 10/10/03 Review Dates: 11/18/04, 9/7/05, 12/21/06, 12/20/07, 12/18/08, 12/16/10, 12/15/11, 4/12/12, 6/20/13, 4/17/14, 5/7/15, 4/14/16, 4/27/17, 6/24/18, 4/23/19, 4/6/20 Revision Dates: 12/19/09 Disclaimer: 1. -
Laparoscopic Antireflux Surgery After Roux-En-Y Gastric Bypass for Obesity
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Biblioteca Digital da Produção Intelectual da Universidade de São Paulo (BDPI/USP) Universidade de São Paulo Biblioteca Digital da Produção Intelectual - BDPI Sem comunidade Scielo 2012 Modified Nissen fundoplication: laparoscopic antireflux surgery after Roux-en-Y gastric bypass for obesity Clinics,v.67,n.5,p.531-533,2012 http://www.producao.usp.br/handle/BDPI/40389 Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo CLINICS 2012;67(5):531-533 DOI:10.6061/clinics/2012(05)23 CASE REPORT Modified Nissen fundoplication: laparoscopic anti- reflux surgery after Roux-en-Y gastric bypass for obesity Nilton T Kawahara,I Clarissa Alster,I Fauze Maluf-Filho,II Wilson Polara,III Guilherme M. Campos,IV Luiz Francisco Poli-de-Figueiredo (in memoriam)I I Faculdade de Medicina da Universidade de Sa˜ o Paulo, (FMUSP), Department of Surgical Technique, Sa˜ o Paulo/SP, Brazil. II Faculdade de Medicina da Universidade de Sa˜ o Paulo, (FMUSP), Department of Gastroenterology, Gastrointestinal Endoscopy Unit, Sa˜ o Paulo/SP, Brazil. III Sı´rio Libaneˆ s Hospital, Department of Oncology Surgery, Sao Paulo/SP, Brazil. IV University of Wisconsin School of Medicine and Public Health, Department of Surgery, Wisconsin/USA. Email: [email protected] Tel.: 55 11 5585 9119 CASE DESCRIPTION (normal ,14.72, 95th percentile). Manometry showed a lower esophageal sphincter pressure (LES) of 9 mmHg (normal A 46-year-old white woman presented to the clinic in range from 14.3 to 34.5 mmHg), and the contraction amplitude September 2009 with intermittent abdominal epigastric pain of the proximal and middle region was greater than 30 mmHg accompanied by nausea, heartburn and frequent crises of (50.6 mmHg).